We support the research and development of innovative technologies through our Stable Isotopes facility, which produces isotopes that are vital for medical, industrial and research applications. We are also bolstering the energy industry’s infrastructure by investing in nuclear new builds through the construction of our Tails Management Facility.
Additionally, our next generation fuels programme at our UK and USA sites (Urenco UK and UUSA) is progressing to enable production of LEU+, low enriched uranium up to 10% uranium-235. LEU+ is a positive initial step towards the subsequent potential production of other advanced fuels for civil nuclear power generation. A project to create an advanced fuels facility has commenced, which will supply research and test reactors, as well as the emerging market to fuel advanced reactors.
Our social impact partnerships, particularly with IAEA and ANS, enable us to collaborate on innovations that support a wide range of industries, from agriculture to medicine. Visit our social impact page to view more information on these partnerships.
Nuclear power capacity worldwide is increasing steadily.
The US has made positive steps in securing support for the continued operations of its existing fleet. Elsewhere, in the UK, nuclear power has been placed at the heart of Britain's target to reach net zero carbon emissions by 2050, and in France, in 2021, President Emmanuel Macron announced that the country will start building new nuclear reactors. To learn more about nuclear expansion see our 2021 annual report.